Skip to content
    Blue Owl Capital logo

    Blue Owl Capital

    New York, New York, United StatesFounded 2016

    Owl Rock Capital Group was a middle-market private credit and direct lending firm founded in 2016 in New York. In May 2021, it merged with Dyal Capital Partners to form Blue Owl Capital Inc. (NYSE: OWL), a leading alternative asset manager.

    Deal activity increased 38% year-over-year (11 deals in the last 12 months). Average disclosed round size is $310.5M (across 65 rounds with reported amounts).

    Find people at Blue Owl Capital on Goldilocks AI

    Portfolio

    59

    Fund Size

    —

    Top Stage

    Growth

    Last 12 Mo

    11

    Team

    CB

    Carly Brooks Prutkin

    Senior Managing Director

    DA

    David Aidi

    Senior Managing Director

    EB

    Eric Brotman

    Senior Managing Director

    EB

    Erik Bissonnette

    Senior Managing Director

    JC

    Jerry Cammarata

    Senior Managing Director

    MC

    Michael Conley

    Senior Managing Director

    ND

    Nicole Drapkin

    Senior Managing Director

    RC

    Ray Chan

    Senior Managing Director

    AC

    Adam Casella

    Managing Director

    AD

    Al Diaz

    Managing Director

    AB

    Allison Benjamin

    Managing Director

    BB

    Bobby Basinski

    Managing Director Tax

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    75 investments
    CompanyRoundAmountDate
    CCapital Integration Systems LLCSeries D$170MJul 2026
    BBridgeBioUnknown$1BJul 2026
    Ambrosia Biosciences Inc. logoAmbrosia Biosciences Inc.Series B$100MMar 2026
    Allica Bank logoAllica BankSeries D—Feb 2026
    Vestwell logoVestwellSeries E—Feb 2026
    Nscale logoNscaleSeries B$1.4BFeb 2026
    Aviceda logoAvicedaSeries C—Jan 2026
    CAIS logoCAISSeries D$170MJan 2026
    Vestwell logoVestwellGrowth—Jan 2026
    Allica Bank logoAllica BankSeries D$155MJan 2026
    Interos logoInterosUnknown$309MJan 2026
    CCoremontGrowth$40MDec 2025
    Crusoe logoCrusoeSeries E$1.4BOct 2025
    Electra logoElectraSeries C$183MOct 2025
    EElectra TherapeuticsSeries C$183MOct 2025
    NNscale Global Holdings LimitedSeries C$433MOct 2025
    Gigabit Fiber, LLC logoGigabit Fiber, LLCUnknown—Sep 2025
    MapLight Therapeutics logoMapLight TherapeuticsSeries D$372.5MJul 2025
    MMadrigal PharmaceuticalsUnknown$500MJul 2025
    Juniper Square logoJuniper SquareSeries D$130MJun 2025
    Latigo Biotherapeutics logoLatigo BiotherapeuticsSeries B$150MMar 2025
    Windward Bio logoWindward BioSeries A$200MJan 2025
    Star Therapeutics logoStar TherapeuticsSeries D$125MJan 2025
    Juniper Square logoJuniper SquareUnknown$130MJan 2025
    Interos logoInterosGrowth$40MOct 2024
    Page 1 of 3

    Top Co-Investors

    Last updated: 20 October 2026